Effects of Ceftriaxone on Body Performance, and Immunological Status of Broilers Experimentally Challenged with E. coli
Marwa Ghandour1*, Gamal A. Shams2, Heba M. Hassan1, Heba A. Baz3 and Walaa Fathy Saad Eldin3
1Animal Health Research Institute, Agriculture Research Center, Cairo, Egypt
2Department of Pharmacology, Faculty of Veterinary Medicine, Zagazig University, 44511 Zagazig, Egypt
3Educational Veterinary Hospital, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
Fig. 1.
Peroxidase stained slides of A) lung of control broilers showing negative expression of CD4 (X200), B) intestine of control broilers showing negative expression of CD4 (X200), C) liver of E. coli-infected broilers showing strong expression of CD4 (X200), D) lung of E. coli-infected broilers showing severe expression of CD4 (X400), E) intestine of E. coli-infected broilers showing strong expression of CD4 (X400), F) liver of E. coli-infected broilers and treated with ceftriaxone showing moderate expression of CD4 (X200), G) lung of E. coli-infected broilers and treated with ceftriaxone showing weak expression of CD4 (X200), H) intestine of E. coli-infected broilers and treated with ceftriaxone showing weak expression of CD4 (X400), at the first-day post-treatment.